Loading...
Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer
BACKGROUND: Targeted therapies, associated with standard chemotherapies, have improved breast cancer care. However, primary and acquired resistances are frequently observed and the development of new concepts is needed. High-throughput approaches to identify new active and safe molecules with or wit...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Public Library of Science
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3445597/ https://ncbi.nlm.nih.gov/pubmed/23028451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0043409 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|